Live Chat Software
February 26-28, 2018
United States

Main Day 1

9:00 am - 9:45 am Defining the Future: Pharmacovigilance (PV) and What’s to Come

Valerie Perentesis, Vice President, Global Medical Safety Operations,Janssen Pharmaceutical
img

Valerie Perentesis

Vice President, Global Medical Safety Operations
Janssen Pharmaceutical

10:00 am - 10:45 am The New International Council for Harmonization (ICH) and What It Means for You

Sylvie Tomczyk, Vice President & Head Global PV & Risk Management,Seqirus
img

Sylvie Tomczyk

Vice President & Head Global PV & Risk Management
Seqirus

11:15 am - 12:00 pm Big Data and the Power of Proactive Pharmacovigilance

David Gao, Director-Physician Drug Safety, Pharmacovigilance,AstraZeneca
img

David Gao

Director-Physician Drug Safety, Pharmacovigilance
AstraZeneca

12:00 pm - 12:45 pm Outsourcing to Increase Efficiency and Cut your Costs

Judith Sills, Vice President and Head, Global Pharmacovigilance,The Medicines Company
img

Judith Sills

Vice President and Head, Global Pharmacovigilance
The Medicines Company

1:45 pm - 2:30 pm How to Interpret and Implement PV Activities in the Context of Externally Sponsored Research

Rodrigo Pimentel Ysla, Medical Director US Med Affairs - Patient Safety & Surveillance,AstraZeneca
img

Rodrigo Pimentel Ysla

Medical Director US Med Affairs - Patient Safety & Surveillance
AstraZeneca

2:30 pm - 3:15 pm Structured Assessment of Benefits and Risks in Drug Regulatory Decision-Making

Tzuyung Douglas Kou, Operational Chair, Risk Management Strategy Committee,Bristol-Myers Squibb
img

Tzuyung Douglas Kou

Operational Chair, Risk Management Strategy Committee
Bristol-Myers Squibb

3:45 pm - 4:30 pm Addressing the Rise in Inspections in 2016 to Zero in on Deficient Areas

Adrian Dana, Vice President, Global Patient Safety and Risk Management,Alnylam
img

Adrian Dana

Vice President, Global Patient Safety and Risk Management
Alnylam

4:30 pm - 5:15 pm Patient Perspective Improving the Drug Development Process

Christine McSherry, Rare Disease Advocate,Duchenne Alliance

Christine McSherry

Rare Disease Advocate
Duchenne Alliance